Report cover image

Global Human MTHFR Gene Polymorphism Detection Kits Market Growth 2026-2032

Published Jan 14, 2026
Length 125 Pages
SKU # LPI20716633

Description

The global Human MTHFR Gene Polymorphism Detection Kits market size is predicted to grow from US$ 138 million in 2025 to US$ 205 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.

Human MTHFR Gene Polymorphism Detection Kits are diagnostic tools designed to identify genetic variations (polymorphisms) in the MTHFR (methylenetetrahydrofolate reductase) gene, which can impact the enzyme's function and influence an individual’s risk for certain health conditions. The MTHFR gene is essential for processing amino acids and is particularly important in the metabolism of folate (vitamin B9), which affects DNA synthesis and repair. Variants of this gene, such as the common C677T and A1298C mutations, are associated with various health risks, including cardiovascular diseases, neural tube defects, and folate metabolism disorders.

United States market for Human MTHFR Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Human MTHFR Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Human MTHFR Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Human MTHFR Gene Polymorphism Detection Kits players cover AID group, Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Xiamen Amplly Biotechnology, Hangzhou DIAN Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Human MTHFR Gene Polymorphism Detection Kits Industry Forecast” looks at past sales and reviews total world Human MTHFR Gene Polymorphism Detection Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Human MTHFR Gene Polymorphism Detection Kits sales for 2026 through 2032. With Human MTHFR Gene Polymorphism Detection Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human MTHFR Gene Polymorphism Detection Kits industry.

This Insight Report provides a comprehensive analysis of the global Human MTHFR Gene Polymorphism Detection Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human MTHFR Gene Polymorphism Detection Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human MTHFR Gene Polymorphism Detection Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human MTHFR Gene Polymorphism Detection Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human MTHFR Gene Polymorphism Detection Kits.

This report presents a comprehensive overview, market shares, and growth opportunities of Human MTHFR Gene Polymorphism Detection Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
C677T
A1298C
Others

Segmentation by Application:
Hospital
Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AID group
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Xiamen Amplly Biotechnology
Hangzhou DIAN Biotechnology
Wuhan HealthCare Biotechnology
Wuhan Kaidewei Biotechnology
Wuxi Ruiqi Gene Biotechnology
Molecule Technology Corporation
Coyote Bioscience
Xiamen Zhishan Biological Technology
Xi'an Tianlong Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human MTHFR Gene Polymorphism Detection Kits market?

What factors are driving Human MTHFR Gene Polymorphism Detection Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human MTHFR Gene Polymorphism Detection Kits market opportunities vary by end market size?

How does Human MTHFR Gene Polymorphism Detection Kits break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

125 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Human MTHFR Gene Polymorphism Detection Kits by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Human MTHFR Gene Polymorphism Detection Kits by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.